Blockchain Registration Transaction Record

KALA BIO Executes 1-for-50 Reverse Stock Split, Advances AI Platform

KALA BIO (NASDAQ: KALA) executes 1-for-50 reverse stock split, reducing shares from 929.5M to 18.6M, while advancing its AI infrastructure platform for biotech. Learn about the split and KALA's Researgency.ai platform.

This reverse stock split is critical for KALA BIO as it consolidates shares to potentially boost stock price and meet Nasdaq listing requirements, which could attract more institutional investors. Additionally, KALA's dual focus on biologics and secure AI infrastructure positions it to revolutionize how biotech companies handle proprietary data, making it a key player in the life sciences AI sector. For investors and industry watchers, this move signals the company's commitment to financial stability and technological innovation.